Cargando…

Directing the Future Breakthroughs in Immunotherapy: The Importance of a Holistic Approach to the Tumour Microenvironment

SIMPLE SUMMARY: Immunotherapies have changed the way we treat cancer and, while some patients have benefitted greatly, there are still those that do not respond to therapy. Understanding why some patients respond to therapy and others do not is critical in developing new immunotherapeutic strategies...

Descripción completa

Detalles Bibliográficos
Autores principales:	Newnes, Hannah V., Armitage, Jesse D., Audsley, Katherine M., Bosco, Anthony, Waithman, Jason
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8656826/ https://www.ncbi.nlm.nih.gov/pubmed/34885021 http://dx.doi.org/10.3390/cancers13235911

Ejemplares similares

Fine-Tuning the Tumour Microenvironment: Current Perspectives on the Mechanisms of Tumour Immunosuppression
por: Armitage, Jesse D., et al.
Publicado: (2021)

Type I interferon subtypes differentially activate the anti-leukaemic function of natural killer cells
por: Barnes, Samantha A., et al.
Publicado: (2022)

Cross-Presenting XCR1(+) Dendritic Cells as Targets for Cancer Immunotherapy
por: Audsley, Katherine M., et al.
Publicado: (2020)

IFNβ Is a Potent Adjuvant for Cancer Vaccination Strategies
por: Audsley, Katherine M., et al.
Publicado: (2021)

Non-severe burn injury increases cancer incidence in mice and has long-term impacts on the activation and function of T cells
por: Barrett, Lucy W, et al.
Publicado: (2022)

Deciphering the Immunological Phenomenon of Adaptive Natural Killer (NK) Cells and Cytomegalovirus (CMV)
por: Barnes, Samantha, et al.
Publicado: (2020)

Diverse Anti-Tumor Immune Potential Driven by Individual IFNα Subtypes
por: Buzzai, Anthony C., et al.
Publicado: (2020)

Knowing the tumour microenvironment to optimise immunotherapy
por: MERLANO, M.C., et al.
Publicado: (2019)

Immunotherapy for pancreatic cancer: Barriers and breakthroughs
por: Torphy, Robert J., et al.
Publicado: (2018)

The most important scientific breakthroughs
Publicado: (2009)

The future of cancer immunotherapy: microenvironment-targeting combinations
por: Murciano-Goroff, Yonina R., et al.
Publicado: (2020)

The Importance of Holistic Care at the End of Life
por: Hackett, Jonathan
Publicado: (2017)

PET/CT imaging for tumour response assessment to immunotherapy: current status and future directions
por: Unterrainer, Marcus, et al.
Publicado: (2020)

Reprogramming the tumour microenvironment by radiotherapy: implications for radiotherapy and immunotherapy combinations
por: Colton, Madyson, et al.
Publicado: (2020)

Tissue-specific tumour microenvironments are an emerging determinant of immunotherapy responses
por: Oliver, Amanda J., et al.
Publicado: (2020)

Neoantigen: A New Breakthrough in Tumor Immunotherapy
por: Zhang, Zheying, et al.
Publicado: (2021)

Holistic Security and Safety for Factories of the Future
por: Maia, Eva, et al.
Publicado: (2022)

Tissue-resident memory T cells orchestrate tumour-immune equilibrium
por: Park, Simone L., et al.
Publicado: (2019)

Current status, challenges and perspectives: immunotherapy and tumour microenvironment in thoracic cancer
por: Luo, Peng, et al.
Publicado: (2020)

Hallmarks of the Tumour Microenvironment of Gliomas and Its Interaction with Emerging Immunotherapy Modalities
por: Linares, Christian A., et al.
Publicado: (2023)

Chemokine-Directed Tumor Microenvironment Modulation in Cancer Immunotherapy
por: Bule, Pedro, et al.
Publicado: (2021)

Cancer Vaccines: Toward the Next Breakthrough in Cancer Immunotherapy
por: Igarashi, Yuka, et al.
Publicado: (2020)

Recent Advances and Next Breakthrough in Immunotherapy for Cancer Treatment
por: Yang, Ling, et al.
Publicado: (2022)

Insights into Cancer Immunotherapies: Recent Breakthroughs, Opportunities, and Challenges
por: Pappas, Evan G., et al.
Publicado: (2023)

Are medical breakthroughs declining – The importance of case reports?
por: Mishra, Sundeep
Publicado: (2015)

Translational Horizons in the Tumor Microenvironment: Harnessing Breakthroughs and Targeting Cures
por: Sun, Yu
Publicado: (2015)

Single cell transcriptomics reveals cell type specific features of developmentally regulated responses to lipopolysaccharide between birth and 5 years
por: Read, James F., et al.
Publicado: (2023)

Future directions for immunotherapy in meningioma treatment
por: Rutland, John W., et al.
Publicado: (2021)

Radiation Response in the Tumour Microenvironment: Predictive Biomarkers and Future Perspectives
por: Byrne, Niall M., et al.
Publicado: (2021)

Barriers to Immunotherapy in Ovarian Cancer: Metabolic, Genomic, and Immune Perturbations in the Tumour Microenvironment
por: Johnson, Racheal Louise, et al.
Publicado: (2021)

Unravelling Tumour Microenvironment in Melanoma at Single-Cell Level and Challenges to Checkpoint Immunotherapy
por: Bai, Xinyu, et al.
Publicado: (2022)

Microbial forensics: new breakthroughs and future prospects
por: Oliveira, Manuela, et al.
Publicado: (2018)

A brand new era of cancer immunotherapy: breakthroughs and challenges
por: Bai, Ri-Lan, et al.
Publicado: (2021)

Editorial: Breakthroughs in immunotherapies and precision treatment against infectious diseases
por: Huang, Ting, et al.
Publicado: (2022)

Breakthroughs of 2015-Personalized Immunotherapy Based on Individual GWAS and Biomarkers
por: Li, Biaoru
Publicado: (2015)

Tumour draining lymph node-generated CD8 T cells play a role in controlling lung metastases after a primary tumour is removed but not when adjuvant immunotherapy is used
por: Fear, Vanessa S., et al.
Publicado: (2021)

Breakthrough Pain: The Importance of Baseline Analgesic Regimen with Opioids
por: Zampi, Maddalena, et al.
Publicado: (2012)

A Holistic Approach to Hard-to-Treat Cancers: The Future of Immunotherapy for Glioblastoma, Triple Negative Breast Cancer, and Advanced Prostate Cancer
por: Puig-Saenz, Carles, et al.
Publicado: (2023)

Correction to: Tumour draining lymph node-generated CD8 T cells play a role in controlling lung metastases after a primary tumour is removed but not when adjuvant immunotherapy is used
por: Fear, Vanessa S., et al.
Publicado: (2021)

Clinical Holistic Medicine: Holistic Pelvic Examination and Holistic Treatment of Infertility
por: Ventegodt, Søren, et al.
Publicado: (2004)

Cannot write session to /tmp/vufind_sessions/sess_1g5kslu9s1flihsrsfvthngnuf